Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9MEX

Structure of phosphocysteine intermediate of human PRL1 phosphatase

Summary for 9MEX
Entry DOI10.2210/pdb9mex/pdb
DescriptorProtein tyrosine phosphatase type IVA 1, SULFATE ION (3 entities in total)
Functional Keywordsphosphatase fold, alpha and beta protein, phosphocysteine, hydrolase
Biological sourceHomo sapiens (human)
Total number of polymer chains2
Total formula weight38121.77
Authors
Mahbub, L.,Kozlov, G.,Knorn, C.,Gehring, K. (deposition date: 2024-12-09, release date: 2025-05-14, Last modification date: 2025-06-25)
Primary citationMahbub, L.,Kozlov, G.,Knorn, C.,Gehring, K.
Structure of the phosphocysteine intermediate of the phosphatase of regenerating liver PTP4A1.
J.Biol.Chem., 301:110251-110251, 2025
Cited by
PubMed Abstract: Phosphatases of regenerating liver (PRL or PTP4A) are protein phosphatases implicated in cell growth, magnesium homeostasis, and cancer metastasis. During catalysis, a phosphocysteine intermediate forms, which must undergo hydrolysis to regenerate the active enzyme. In addition to dephosphorylating substrates, PRLs act as pseudo-phosphatases and bind CBS-pair domain divalent metal cation transport mediators (CNNMs) to regulate magnesium transport. In this study, we investigate the role of PRL residues in phosphocysteine hydrolysis using mutagenesis, enzyme assays, and X-ray crystallography. Loss of an aspartic acid and cysteine in the catalytic site disrupts hydrolysis and stabilizes the phosphocysteine intermediate for weeks. We use this C49S/D72A double mutant to determine the crystal structure of the cysteine-phosphorylated form of PRL1 (PTP4A1). The structure confirms that phosphocysteine sterically interferes with CNNM binding, consistent with previous biochemical studies. In vitro enzyme assays reveal the aspartic acid mutation increases the initial rate of catalysis for all three PRL paralogs while the homologous mutation in the phosphatases, PTP1B and PTPN12, disrupts catalysis. This highlights the mechanistic differences between PRLs and classical protein tyrosine phosphatases. Our findings refine our understanding of PRL catalysis and identify novel mutations for investigating PRL function in cancer and magnesium homeostasis.
PubMed: 40398601
DOI: 10.1016/j.jbc.2025.110251
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.6 Å)
Structure validation

250059

PDB entries from 2026-03-04

PDB statisticsPDBj update infoContact PDBjnumon